Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension
- 1 January 1993
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 71 (3) , A12-A16
- https://doi.org/10.1016/0002-9149(93)90239-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cardiac interstitium in health and disease: The fibrillar collagen networkPublished by Elsevier ,2010
- Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.Circulation, 1991
- Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophyCardiovascular Research, 1988
- Collagen chain mRNAs in isolated heart cells from young and adult rats*Journal of Molecular and Cellular Cardiology, 1988
- Physiologic Versus Pathologic Hypertrophy and the Pressure-Overloaded MyocardiumJournal of Cardiovascular Pharmacology, 1987
- True versus immunoreactive angiotensin II in human plasma.Hypertension, 1985
- Connective tissue content and myocardial stiffness in pressure overload hypertrophy A combined study of morphologic, morphometric, biochemical, and mechanical parametersBasic Research in Cardiology, 1983
- Aldosterone infusion into the rat and dose-dependent changes in blood pressure and arterial ionic transport.Hypertension, 1982
- Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aortaJournal of Steroid Biochemistry, 1981
- Ultrastructure of coronary arteries and myocardium in experimental hypertensionExperimental and Molecular Pathology, 1978